forxiga • 10 mg
dapagliflozine
Product Insights
Dapagliflozine (brand name Forxiga) is a 10 mg oral tablet used to treat type 2 diabetes by inhibiting the sodium-glucose co-transporter-2 (SGLT2) in the kidneys, which reduces blood glucose reabsorption. The tablet contains the active ingredient dapagliflozine together with excipients such as lactose anhydrous, silicon dioxide, crospovidone, polyvinyl alcohol, titanium dioxide, talc and yellow iron oxide, providing stability and tablet integrity. Potential drawbacks include lactose, which may affect lactose-intolerant patients, and titanium dioxide, a pigment currently under regulatory scrutiny, so patients should consult their healthcare provider before use.
Comparative Analysis
Compared with other SGLT2 inhibitors, this Forxiga 10 mg tablet offers a low dose in a simple tablet format and a limited excipient list, positioning it as a convenient oral option for glycemic control.
Ingredients
lactose anhydre dioxyde de silicium crospovidone alcool polyvinylique dioxyde de titane macro golf talc oxyde de fer jaune
Unlock Full Product Insights
Scan this and millions of other daily products to reveal hidden ingredients, safety alerts, and comprehensive analysis with the free NutrScan app.
Frequently Asked Questions
Everything you need to know about dapagliflozine.
